10.1007/s00125-006-0144-4
Crossref journal-article
Springer Science and Business Media LLC
Diabetologia (297)
Bibliography

Christodoulides, C., Scarda, A., Granzotto, M., Milan, G., Dalla Nora, E., Keogh, J., De Pergola, G., Stirling, H., Pannacciulli, N., Sethi, J. K., Federspil, G., Vidal-Puig, A., Farooqi, I. S., O’Rahilly, S., & Vettor, R. (2006). WNT10B mutations in human obesity. Diabetologia, 49(4), 678–684.

Authors 15
  1. C. Christodoulides (first)
  2. A. Scarda (additional)
  3. M. Granzotto (additional)
  4. G. Milan (additional)
  5. E. Dalla Nora (additional)
  6. J. Keogh (additional)
  7. G. De Pergola (additional)
  8. H. Stirling (additional)
  9. N. Pannacciulli (additional)
  10. J. K. Sethi (additional)
  11. G. Federspil (additional)
  12. A. Vidal-Puig (additional)
  13. I. S. Farooqi (additional)
  14. S. O’Rahilly (additional)
  15. R. Vettor (additional)
References 18 Referenced 115
  1. MacDougald OA, Mandrup S (2002) Adipogenesis: forces that tip the scales. Trends Endocrinol Metab 13:5–11 (10.1016/S1043-2760(01)00517-3) / Trends Endocrinol Metab by OA MacDougald (2002)
  2. Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810 (10.1146/annurev.cellbio.20.010403.113126) / Annu Rev Cell Dev Biol by CY Logan (2004)
  3. Willert K, Brown JD, Danenberg E et al (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448–452 (10.1038/nature01611) / Nature by K Willert (2003)
  4. Miller JR (2002) The Wnts. Genome Biol 3:REVIEWS3001
  5. Ross SE, Hemati N, Longo KA et al (2000) Inhibition of adipogenesis by Wnt signaling. Science 289:950–953 (10.1126/science.289.5481.950) / Science by SE Ross (2000)
  6. Bennett CN, Ross SE, Longo KA et al (2002) Regulation of Wnt signaling during adipogenesis. J Biol Chem 277:30998–31004 (10.1074/jbc.M204527200) / J Biol Chem by CN Bennett (2002)
  7. Longo KA, Wright WS, Kang S et al (2004) Wnt10b inhibits development of white and brown adipose tissues. J Biol Chem 279:35503–35509 (10.1074/jbc.M402937200) / J Biol Chem by KA Longo (2004)
  8. Hung CC, Pirie F, Luan J et al (2004) Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human obesity and obesity-related traits. Diabetes 53:2461–2466 (10.2337/diabetes.53.9.2461) / Diabetes by CC Hung (2004)
  9. Cole TJ, Freeman JV, Preece MA (1998) British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 17:407–429 (10.1002/(SICI)1097-0258(19980228)17:4<407::AID-SIM742>3.0.CO;2-L) / Stat Med by TJ Cole (1998)
  10. Williams DR, Wareham NJ, Brown DC et al (1995) Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 12:30–35 (10.1111/j.1464-5491.1995.tb02058.x) / Diabet Med by DR Williams (1995)
  11. Saitoh T, Kirikoshi H, Mine T, Katoh M (2001) Proto-oncogene WNT10B is up-regulated by tumor necrosis factor alpha in human gastric cancer cell line MKN45. Int J Oncol 19:1187–1192 / Int J Oncol by T Saitoh (2001)
  12. Nugent C, Prins JB, Whitehead JP et al (2001) Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. Mol Endocrinol 15:1729–1738 / Mol Endocrinol by C Nugent (2001)
  13. Xu H, Sethi JK, Hotamisligil GS (1999) Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1. J Biol Chem 274:26287–26295 (10.1074/jbc.274.37.26287) / J Biol Chem by H Xu (1999)
  14. Sewter CP, Blows F, Vidal-Puig A, O’Rahilly S (2002) Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists. Diabetes 51:718–723 (10.2337/diabetes.51.3.718) / Diabetes by CP Sewter (2002)
  15. Culbert AA, Brown MJ, Frame S et al (2001) GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. FEBS Lett 507:288–294 (10.1016/S0014-5793(01)02990-8) / FEBS Lett by AA Culbert (2001)
  16. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O’Rahilly S (2003) Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348:1085–1095 (10.1056/NEJMoa022050) / N Engl J Med by IS Farooqi (2003)
  17. Dierick HA, Bejsovec A (1998) Functional analysis of wingless reveals a link between intercellular ligand transport and dorsal-cell-specific signaling. Development 125:4729–4738 (10.1242/dev.125.23.4729) / Development by HA Dierick (1998)
  18. Bennett CN, Longo KA, Wright WS et al (2005) Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102:3324–3329 (10.1073/pnas.0408742102) / Proc Natl Acad Sci USA by CN Bennett (2005)
Dates
Type When
Created 19 years, 6 months ago (Feb. 13, 2006, 10:14 a.m.)
Deposited 4 years, 1 month ago (July 23, 2021, 5:08 p.m.)
Indexed 6 days, 11 hours ago (Aug. 20, 2025, 9 a.m.)
Issued 19 years, 6 months ago (Feb. 14, 2006)
Published 19 years, 6 months ago (Feb. 14, 2006)
Published Online 19 years, 6 months ago (Feb. 14, 2006)
Published Print 19 years, 4 months ago (April 1, 2006)
Funders 0

None

@article{Christodoulides_2006, title={WNT10B mutations in human obesity}, volume={49}, ISSN={1432-0428}, url={http://dx.doi.org/10.1007/s00125-006-0144-4}, DOI={10.1007/s00125-006-0144-4}, number={4}, journal={Diabetologia}, publisher={Springer Science and Business Media LLC}, author={Christodoulides, C. and Scarda, A. and Granzotto, M. and Milan, G. and Dalla Nora, E. and Keogh, J. and De Pergola, G. and Stirling, H. and Pannacciulli, N. and Sethi, J. K. and Federspil, G. and Vidal-Puig, A. and Farooqi, I. S. and O’Rahilly, S. and Vettor, R.}, year={2006}, month=feb, pages={678–684} }